During the past decade, Hopital Pellegrin; Departement Nephrologie conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 1 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hopital Pellegrin; Departement Nephrologie" #1 collaborator was "Genzyme, a Sanofi Company" with 1 trials as a collaborator and "Hoffmann-La Roche" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Hopital Pellegrin; Departement Nephrologie" are "Chronic Renal Anemia" (1 trials), "Chronic Renal Failure" (1 trials), "Cytomegalovirus Infections" (1 trials), "Ischemia" (1 trials) and "Renal Anemia of Chronic Kidney Disease" (1 trials). Many other conditions were trialed in "Hopital Pellegrin; Departement Nephrologie" in a lesser frequency.

Most popular intervention types in "Hopital Pellegrin; Departement Nephrologie" are "Drug" (5 trials). Other intervention types were less common.

The name of intervention was led by "Darbepoetin Alfa" (1 trials), "Epoetin Alfa" (1 trials), "Epoetin Beta" (1 trials), "Methoxy Polyethylene Glycol-Epoetin Beta" (1 trials) and "Placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hopital Pellegrin; Departement Nephrologie" are 5 trials for "All" genders.

Currently, there are NaN active trials in "Hopital Pellegrin; Departement Nephrologie". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Hopital Pellegrin; Departement Nephrologie, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Hopital Pellegrin; Departement Nephrologie, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".